Modest Gains in Life Expectancy Seen for Dialysis in Older Adults With eGFR
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 19, 2024 -- For older adults, starting dialysis when the estimated glomerular filtration rate (eGFR) falls below 12 mL/min/1.73 m2 results in modest gains in life expectancy, according to a study published online Aug. 20 in the Annals of Internal Medicine.
Maria E. Montez-Rath, Ph.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues conducted an observational cohort study using target trial emulation involving adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m2 who were not referred for transplant. Survival and home time were compared between those who started dialysis and those who continued medical management.
The researchers found that median time to dialysis start among the 20,440 adults was 8.0 days and 3.0 years in the group starting dialysis and the group continuing medical management, respectively. During a three-year period, the groups starting dialysis and continuing medical management survived 770 and 761 days, respectively. The group starting dialysis had 13.6 fewer days at home compared with the group continuing medical management. The group starting dialysis had longer survival by 77.6 days and 14.7 fewer days at home compared with the group continuing medical management and forgoing dialysis completely.
"Decisions to start dialysis at this level of kidney function should consider the clinical factors that affect this tradeoff and whether the expected outcomes of starting dialysis align with an individual's values and goals," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Exposure to Trihalomethanes Linked to Chronic Kidney Disease
TUESDAY, July 8, 2025 -- Exposure to trihalomethanes, especially brominated trihalomethanes, in residential community water supplies (CWS) is associated with an increased risk for...
Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
THURSDAY, June 26, 2025 -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial...
Biomarker Panel Improves Prediction of CKD Progression in Children
TUESDAY, June 24, 2025 -- A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study published in the June issue of the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.